ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,424,000 | +35.2% | 8,274 | -1.4% | 0.08% | +40.4% |
Q2 2021 | $1,053,000 | -26.1% | 8,389 | -20.1% | 0.06% | -29.6% |
Q1 2021 | $1,424,000 | +72.8% | 10,503 | +63.1% | 0.08% | +37.3% |
Q4 2020 | $824,000 | -58.7% | 6,441 | -63.6% | 0.06% | -9.2% |
Q3 2020 | $1,994,000 | -34.1% | 17,718 | -44.2% | 0.06% | -16.7% |
Q2 2020 | $3,024,000 | +102.7% | 31,737 | +91.2% | 0.08% | +100.0% |
Q1 2020 | $1,492,000 | +69.0% | 16,599 | -0.3% | 0.04% | +225.0% |
Q4 2019 | $883,000 | – | 16,651 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |